BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 30985575)

  • 41. Post-transplant obesity impacts long-term survival after liver transplantation.
    van Son J; Stam SP; Gomes-Neto AW; Osté MCJ; Blokzijl H; van den Berg AP; Porte RJ; Bakker SJL; de Meijer VE
    Metabolism; 2020 May; 106():154204. PubMed ID: 32173406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
    Li T; Liu J; Zhao J; Bai Y; Huang S; Yang C; Wang Y; Zhou C; Wang C; Ju S; Chen Y; Yao W; Xiong B
    Dig Dis Sci; 2023 Apr; 68(4):1641-1652. PubMed ID: 36583804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sarcopenia adversely impacts postoperative complications in living-donor liver transplantation recipients.
    Wu MY; Lim WX; Cheng YF; Chang CD; Hsu HW; Lin CC; Chen CL; Chang WC; Yu CY; Tsang LL; Chuang YH; Ou HY
    Sci Rep; 2021 Sep; 11(1):19247. PubMed ID: 34584142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Kamo N; Okajima H; Uemoto S
    Transplantation; 2017 Mar; 101(3):565-574. PubMed ID: 27926595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low psoas muscle index as an unfavorable factor in children with end-stage liver disease undergoing liver transplantation.
    Jitwongwai S; Lertudomphonwanit C; Junhasavasdikul T; Fuangfa P; Tanpowpong P; Gesprasert G; Treepongkaruna S
    Pediatr Transplant; 2021 Aug; 25(5):e13996. PubMed ID: 33734542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sarcopenia as prognostic factor for survival after orthotopic liver transplantation.
    Pinto Dos Santos D; Kloeckner R; Koch S; Hoppe-Lotichius M; Zöller D; Toenges G; Kremer WM; Zimmermann T; Mittler J; Lang H; Düber C; Galle PR; Weinmann A; Sprinzl MF
    Eur J Gastroenterol Hepatol; 2020 May; 32(5):626-634. PubMed ID: 31725030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cirrhosis-related sarcopenia may not resolve after liver transplantation.
    Brown S; Richardson B; Bouquet E; Reid E; Mercer E; Goncalves M; Spann A; Annis J; Brittain E; Dreher A; Alexopoulos S; Slaughter JC; Silver HJ; Izzy M
    JHEP Rep; 2023 Nov; 5(11):100881. PubMed ID: 37771367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of the third lumbar skeletal muscle mass index in patients with liver cirrhosis and ascites.
    Yao J; Zhou X; Yuan L; Niu LY; Zhang A; Shi H; Duan Z; Xu J
    Clin Nutr; 2020 Jun; 39(6):1908-1913. PubMed ID: 31472986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
    Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
    J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of sarcopenia on post-liver transplant morbidity and mortality in cirrhotic patients.
    Kumar VV; Kothakota SR; Nair AK; Sasidharan M; Kareem H; Kanala J; Kumar CP
    Indian J Gastroenterol; 2022 Oct; 41(5):440-445. PubMed ID: 36342633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sarcopenia and liver transplant: The relevance of too little muscle mass.
    Kallwitz ER
    World J Gastroenterol; 2015 Oct; 21(39):10982-93. PubMed ID: 26494955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of sarcopenia on the survival of patients undergoing liver transplantation for decompensated liver cirrhosis.
    Zhou D; Zhang D; Zeng C; Zhang L; Gao X; Wang X
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2602-2612. PubMed ID: 37735907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation.
    Chae MS; Moon KU; Jung JY; Choi HJ; Chung HS; Park CS; Lee J; Choi JH; Hong SH
    Liver Transpl; 2018 May; 24(5):623-633. PubMed ID: 29365358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphometric parameters of muscle and bone in critically ill patients : Post hoc analysis of the VITdAL-ICU trial.
    Malle O; Maurer D; Wagner D; Schnedl C; Amrein S; Pieber T; Fahrleitner-Pammer A; Dimai HP; Amrein K
    Wien Klin Wochenschr; 2021 Jun; 133(11-12):529-535. PubMed ID: 32945947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation.
    Golse N; Bucur PO; Ciacio O; Pittau G; Sa Cunha A; Adam R; Castaing D; Antonini T; Coilly A; Samuel D; Cherqui D; Vibert E
    Liver Transpl; 2017 Feb; 23(2):143-154. PubMed ID: 28061014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality.
    Aby ES; Lee E; Saggi SS; Viramontes MR; Grotts JF; Agopian VG; Busuttil RW; Saab S
    J Clin Gastroenterol; 2019 Oct; 53(9):680-685. PubMed ID: 30180152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. L3 Skeletal Muscle Index Dynamics in Patients with HCV-Related Compensated Cirrhosis Following Sustained Virological Response after Direct Acting Antiviral Treatment.
    Mihai F; Trifan A; Stanciu C; Huiban L; Muzîca C; Lupașcu-Ursulescu C; Negru D; Savin ML; Gîrleanu I; Cuciureanu T; Sîngeap AM
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833444
    [No Abstract]   [Full Text] [Related]  

  • 59. Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Lai JC; Covinsky KE; Dodge JL; Boscardin WJ; Segev DL; Roberts JP; Feng S
    Hepatology; 2017 Aug; 66(2):564-574. PubMed ID: 28422306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.